DYN

NASDAQStock

Dyne Therapeutics, Inc.

$17.71-0.35 (-1.95%)

52-Week Range

$6.81

$24.29

Key Stats

Market Cap

2.9B

P/E Ratio

—

Dividend Yield

—

Beta

1.40

Volume

1.7M

Avg Volume

2.7M

Performance

+12.87%

-7.81%

+40.44%

YTD

-2.38%

+49.88%

+42.99%

+7.69%

Price Chart

ETF Exposure

DYN is held by 110 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	226	$5K	$820.6M	0.25%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	3	$59	$26.2M	0.50%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	10	$208	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	34	$687	$80.3M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	3,111	$52K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	3,111	$52K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	3,111	$52K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	3,111	$52K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	3,111	$52K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	39	$948	$337.7M	0.32%

PreviousPage 3 of 3

About DYN ETF Exposure

Dyne Therapeutics, Inc. (DYN) is held by 110 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.9B, DYN is a widely held institutional stock. The stock currently trades at $17.71. Investors can gain exposure to DYN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold DYN, sorted by portfolio weight.